Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells
Open accessIntegrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A decade ago, a study first showed successful reprogramming of blood cells using non-integrative SeV as an efficient integration-free gene delivery method.
“In addition, a study published a decade ago showed for the first time the successful reprogramming of blood cells using non-integrative SeV as an efficient integration-free gene delivery method [139].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [139]
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673 · see citing works
Suppression of induced pluripotent stem cell generation by the p53–p21 pathway
Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., & Yamanaka, S. (2009) · Nature · doi:10.1038/nature08235 · Cited by 1,301 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Generation of human induced pluripotent stem cells from urine samples
Zhou, T., Benda, C., Dunzinger, S., Huang, Y., Ho, J. C., Yang, J., Wang, Y., Zhang, Y., Zhuang, Q., Li, Y., et al. (2012) · Nature Protocols · doi:10.1038/nprot.2012.115 · Cited by 614 · see citing works
Generation of induced pluripotent stem cells from urine
Zhou, T., Benda, C., Duzinger, S., Huang, Y., Li, X., Li, Y., Guo, X., Cao, G., Chen, S., Hao, L., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011010106 · Cited by 421 · see citing works
Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells
Nakamura, M., & Okano, H. (2013) · Cell Research · doi:10.1038/cr.2012.171 · Cited by 214 · see citing works
Disease characterization using LQTS-specific induced pluripotent stem cells
Egashira, T., Yuasa, S., Suzuki, T., Aizawa, Y., Yamakawa, H., Matsuhashi, T., Ohno, Y., Tohyama, S., Okata, S., Seki, T., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs206 · Cited by 178 · see citing works
Nakanishi, M., & Otsu, M. (2012) · Current Gene Therapy · doi:10.2174/156652312802762518 · Cited by 147 · see citing works
Minegishi, Y., Iejima, D., Kobayashi, H., Chi, Z.-L., Kawase, K., Yamamoto, T., Seki, T., Yuasa, S., Fukuda, K., & Iwata, T. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt210 · Cited by 138 · see citing works
Self-citationiPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter?
Scesa, G., Adami, R., & Bottai, D. (2021) · Cells · doi:10.3390/cells10061470 · Cited by 110 · see citing works
Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through
Gurumoorthy, N., Nordin, F., Tye, G. J., Wan Kamarul Zaman, W. S., & Ng, M. H. (2022) · Biomedicines · doi:10.3390/biomedicines10010107 · Cited by 69 · see citing works
- Authors
- Seki, T., Yuasa, S., Oda, M., Egashira, T., Yae, K., Kusumoto, D., Nakata, H., Tohyama, S., Hashimoto, H., Kodaira, M., Okada, Y., Seimiya, H., Fusaki, N., Hasegawa, M., & Fukuda, K.
- Affiliations
- Keio University (JP)
- Center for Integrated Medical Research, Keio University (JP)
- Japanese Foundation For Cancer Research (JP)
- Japan Science and Technology Agency (JP)
- ID Pharma (Japan) (JP)
- Corresponding author
- Fukuda, Keiichi
- ORCID
- Venue
- Cell Stem Cell
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 7
- Issue
- 1
- Pages
- 11-14
- ISSN
- 1875-9777 (ISSN-L)
- 1934-5909
- OpenAlex
- W2002943691
- Cited by
- 584
- References
- 2
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 13 · 2023: 18 · 2022: 24 · 2021: 40 · 2020: 20 · 2019: 24 · 2018: 40 · 2017: 26 · 2016: 57 · 2015: 49 · 2014: 50 · 2013: 71 · 2012: 58
- FWCI
- 25.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell stem cell (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- induced pluripotent stem cells, T cells, direct reprogramming, somatic cell reprogramming, peripheral blood T cells, human induced pluripotent stem cells, terminally differentiated cells
- MeSH terms
- Kruppel-Like Factor 4, Organic Cation Transporter 3, Cell Differentiation, Cells, Cultured, Fluorescent Antibody Technique, Humans, T-Lymphocytes, Temperature, Proto-Oncogene Proteins c-myc, Cell Culture Techniques, Electrophoresis, Capillary, Reverse Transcriptase Polymerase Chain Reaction, Organic Cation Transport Proteins, Sendai virus, Octamer Transcription Factor-3, Kruppel-Like Transcription Factors, SOXB1 Transcription Factors, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
